What UK clinical guidance says The Wegovy Summary of Product Characteristics (the formal MHRA-approved prescribing document) section 4.6 states that semaglutide shouldnt be used during pregnancy, and that if a patient wishes to become pregnant, semaglutide should be stopped at least two months before a planned pregnancy due to the long half-life
Effects May improve exercise performance and recovery in those who are low in magnesium status
Poor medication adherence significantly impacts treatment outcomes
GLP-1 Assisted Transition to Suzetrigine or Other Non-Addictive Painkillers Does semaglutide or tirzepatide (given at first visit and ongoing) increase the success rate of transitioning chronic pain patients from opioids to suzetrigine, aka Vertex VX-548
Next, the same image scaled to 80% of the original size was shown with the words How much do you want to eat this? for 2.5 s
DEXA scans were performed and assessed by blinded personnel, and statistical analyses were planned prior to unblinding at the end of the treatment period